AlloVir, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALVR research report →
About the company
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections.
- CEO
- Vikas Sinha CPA,
- IPO
- 2020
- Employees
- 6
- HQ
- Waltham, MA, US
Price Chart
- Market Cap
- $49.48M
- P/E
- -2.21
- P/S
- 0.00
- P/B
- 1.64
- EV/EBITDA
- -1.27
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -72.78%
- ROIC
- -46.68%
- Revenue
- $0 · 0.00%
- Net Income
- $-43,438,000 · 26.09%
- EPS
- $-2.85 · 75.70%
- Op Income
- $-46,152,000
- FCF YoY
- 43.03%
- 52W High
- $24.15
- 52W Low
- $7.96
- 50D MA
- $9.73
- 200D MA
- $14.55
- Beta
- 0.62
- Avg Volume
- 22.94K
Get TickerSpark's AI analysis on ALVR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 21, 25 | Sinha Vikas | sell | 303 |
| Feb 21, 25 | Hagen Brett R | sell | 96 |
| Feb 21, 25 | Miller Edward | sell | 106 |
| Jan 23, 25 | Miller Edward | sell | 47 |
| Jan 23, 25 | Miller Edward | sell | 5 |
| Jan 23, 25 | Hagen Brett R | sell | 32 |
| Jan 23, 25 | Hagen Brett R | sell | 4 |
| Jan 23, 25 | Sinha Vikas | sell | 116 |
| Jan 23, 25 | Sinha Vikas | sell | 13 |
| Jan 10, 25 | Miller Edward | sell | 409 |
Our ALVR coverage
Recent articles, reports, and earnings notes.
No research on ALVR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALVR report →Similar companies
Peers in the same neighborhood.